Synthivan Tablet is an antiretroviral medication which is used to treat and prevent HIV/AIDS. It is usually recommended to use with other antiretroviral. It may also be used for prevention after a needlestick injury or other potential exposure. It is directed to be taken via the mouth once a day. Synthivan Tablet binds itself to the active site of HIV protease and prevents it from splitting the pro-form of viral proteins into the working machinery of the virus. If the HIV protease enzyme does not work then the virus is not infectious, and no mature virions are made.
Common side effects include yellowish skin, headache, abdominal pain, nausea, trouble sleeping, and fever. Severe side effects include rashes such as erythema multiform and high blood sugar. Synthivan Tablet appears to be safe to use during pregnancy. It is of the protease inhibitor (PI) class and works by blocking HIV protease. Synthivan Tablet should not be taken by those with hypersensitivity. Synthivan Tablet should not be taken with other medications such as triazolam, lurasidone, alfuzosin, irinotecan, rifampin, pimozide, orally administered lovastatin, midazolam, cisapride, ergot derivatives.
Is It safe with alcohol?Interaction with alcohol is unknown. Please consult your doctor.
Are there any pregnancy warnings?Ritovaz 300 mg/100 mg tabcap is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Are there any breast-feeding warnings?Ritovaz 300 mg/100 mg tabcap is probably unsafe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?Patients should be informed that dizziness has been reported during treatment.
Does this affect kidney function?There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
This medication behaves as a protease inhibitor which blocks the activity of HIV protease. This interferes with the maturation process of HIV and leads to the production of viruses which are damaged or defective proteins and is unable to infect the healthy cells of the body.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.